Bienvenue près de ERA – Académie de Droit Européen


ZUSATZNAVIGATION

Mon ERA

Signets

Panier
Grafik-Link: Button Login.
0 pages
0 entrées


SCHMUCKBILD + LOGO


INHALT


BREADCRUMB


Conférence bisannuelle sur le droit pharmaceutique européen

, 15 avril 2010 – 16 avril 2010
Langue:

Référence:
210R02

Domaine de droit:

This conference will offer an overview of the latest innovations in European legislative activity and the most important recent case law and pending judgments of the Court of Justice of the European Union (CJEU) affecting the pharmaceutical sector:

Pharmaceutical law and competition law
  • Pending CJEU rulings on Article 101 TFEU such as GSK (C-501/06) and on Article 102 such as AstraZeneca (T-321/05) and pending cases before the European Commission
  • The way forward the pharmaceutical sector inquiry
Pharmaceutical law and intellectual property law
  • Follow-up of the legislative proposal on counterfeiting of medicines (COM(2008)668)
  • Pharmaceutical patent litigation settlements, patent linkage, licensing agreements
  • Follow-up to the proposal for a unified patent litigation system
The future of pharmaceutical law in Europe
  • New projects in the pipeline, including the current discussions on the clinical trial directive, follow-up of the 2008 pharmaceutical legislative package
  • Emerging new technologies and legal status of borderline products


Liste de diffusion


DOCUMENTS


Programme

IMPORTANT NOTE


Note importante
Votre participation à cette conférence peut contribuer à votre formation professionnelle continue.

ORGANISER



SERVICE

  • Logo: Facebook
  • Logo: Twitter
  • Logo: Youtube
  • Logo: LinkedIn